DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer

Despite the advantages of neoadjuvant chemotherapy (NACT), associated toxicity is a serious complication that renders monitoring of the patients’ response to NACT highly important. Thus, prediction of tumor response to treatment is imperative to avoid exposure of potential non-responders to deleteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Sigin, Vladimir O., Kalinkin, Alexey I., Kuznetsova, Ekaterina B., Simonova, Olga A., Chesnokova, Galina G., Litviakov, Nikolai V., Slonimskaya, Elena M., Tsyganov, Matvey M., Ibragimova, Marina K., Volodin, Ilya V., Vinogradov, Ilya I., Vinogradov, Maksim I., Vinogradov, Igor Y., Kutsev, Sergey I., Strelnikov, Vladimir V., Zaletaev, Dmitry V., Tanas, Alexander S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280523/
https://www.ncbi.nlm.nih.gov/pubmed/32514046
http://dx.doi.org/10.1038/s41598-020-66197-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280523/
https://www.ncbi.nlm.nih.gov/pubmed/32514046
http://dx.doi.org/10.1038/s41598-020-66197-1

Ejemplares similares